GAP Experts Share Poster Presentations at Alzheimer’s Association International Conference (AAIC)
Washington D.C., July 9, 2026- The Global Alzheimer’s Platform Foundation®, (GAP) will have two poster presentations at the 2026 Alzheimer’s Association International Conference (AAIC) being held in Londong July 12 through July 15. All posters are in the Exhibit Hall in Excel London, Royal Victoria Dock, 1 Western Gateway, London.
“A Comparison of Flortaucipir and MK6240 Tau PET Positivity Rates in the Bio-Hermes-002 study“
Who: Lammert Albers, Chief Commercial Officer, Global Alzheimer’s Platform Foundation
When: Sunday, July 12, 7:30 AM-4:15PM GMT
“Expanding clinical trial access to Underrepresented Populations in the U.S.: Findings from the Alzheimer’s Disease Pre-Screener Study”
Who: Irma Kurniawan¹*; Tamiko MaGee-Rodgers²*; Luisa Guglielmini³; Justin Ford²; Mia Chester²; Theo Christofides4; Enrique Gaspar¹; Kelly Coultes5; Christopher Lane4; Lisa Squassante¹; Nicola Maiorano¹; Julian Tillmann¹; Rosanna Tortelli¹; Ruth Croney4
¹ F. Hoffmann-La Roche Ltd, Basel, Switzerland; ² Global Alzheimer’s Platform Foundation, Washington, DC, USA; ³Genentech, Inc., South San Francisco, CA, USA; Roche Products Ltd, Welwyn Garden City, UK; Hoffmann-La Roche Ltd, Mississauga, ON, Canada. (*Joint first authors.)
When: Sunday, July 12, 7:30 AM-4:15PM GMT
GAP can arrange interviews surrounding the presentations and for more information on GAP, visit globalalzplatform.org/.
END
About GAP
The Global Alzheimer’s Platform Foundation® (GAP) is a person-centered nonprofit organization dedicated to accelerating the delivery of innovative therapies for neurological disorders by reducing the duration and cost of clinical trials. Over 100 research centers around the world are part of the growing GAP Network (GAP-Net).